Improving contracts with payers can earn rheumatologists more money, with no added costs in staffing or equipment
Tom Collins is a freelance writer in South Florida, who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
Articles by Thomas R. Collins
ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs
ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis
Rheumatology experts urge caution in using bisphosphonates to prevent bone loss
ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease
More finely tuned view of ankylosing spondylitis leads to better treatment, expert says
Tech Talk: New Platform Aims to Make Telephone Communication Simpler
MedXCom system helps physicians better manage their phone calls with patients
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
Tech Talk: Making Electronic Health Records Easier
Digital pens linked to electronic medical records can be a simple way for doctors to make the transition
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.